Lai JI - Search Results

1

Correlation of an immune-related 8-gene panel with pathologic response to neoadjuvant chemotherapy in patients with primary breast cancers.

Tseng LM, Huang CC, Tsai YF, Chen JL, Chao TC, Lai JI, Lien PJ, Lin YS, Feng CJ, Chen YJ, Chiu JH, Hsu CY, Liu CY. Tseng LM, et al. Among authors: lai ji. Transl Oncol. 2023 Dec;38:101782. doi: 10.1016/j.tranon.2023.101782. Epub 2023 Sep 13. Transl Oncol. 2023. PMID: 37713974 Free PMC article.

2

Concomitant Genetic Alterations are Associated with Worse Clinical Outcome in EGFR Mutant NSCLC Patients Treated with Tyrosine Kinase Inhibitors.

Chang SC, Lai YC, Chang CY, Huang LK, Chen SJ, Tan KT, Yu PN, Lai JI. Chang SC, et al. Among authors: lai yc, lai ji. Transl Oncol. 2019 Nov;12(11):1425-1431. doi: 10.1016/j.tranon.2019.07.008. Epub 2019 Aug 8. Transl Oncol. 2019. PMID: 31401335 Free PMC article.

3

Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast Cancers.

Huang CC, Tsai YF, Liu CY, Lien PJ, Lin YS, Chao TC, Feng CJ, Chen YJ, Lai JI, Phan NN, Hsu CY, Chiu JH, Tseng LM. Huang CC, et al. Among authors: lai ji. Ann Surg Oncol. 2022 Jun;29(6):3578-3590. doi: 10.1245/s10434-022-11347-0. Epub 2022 Feb 28. Ann Surg Oncol. 2022. PMID: 35226219

4

A generational comparison for unfavorable cancer of unknown primary in a single institute over 20 years.

Tang CY, Hang JF, Hung YP, Chiu NC, Lai JI, Chen MH, Liu CY, Yang MH, Chao Y, Chang PM. Tang CY, et al. Among authors: lai ji. Cancer Med. 2023 Jan;12(2):1090-1101. doi: 10.1002/cam4.4960. Epub 2022 Jul 3. Cancer Med. 2023. PMID: 35781808 Free PMC article.

5

CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin-proteasome pathway in ER + breast cancer.

Lin CY, Yu CJ, Liu CY, Chao TC, Huang CC, Tseng LM, Lai JI. Lin CY, et al. Among authors: lai ji. Clin Transl Oncol. 2022 Nov;24(11):2120-2135. doi: 10.1007/s12094-022-02881-0. Epub 2022 Aug 2. Clin Transl Oncol. 2022. PMID: 35917055

6

[No title available]

[No authors listed] [No authors listed] PMID: 36042100

7

Correction to: CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin-proteasome pathway in ER + breast cancer.

Lin CY, Yu CJ, Liu CY, Chao TC, Huang CC, Tseng LM, Lai JI. Lin CY, et al. Among authors: lai ji. Clin Transl Oncol. 2022 Nov;24(11):2251-2253. doi: 10.1007/s12094-022-02928-2. Clin Transl Oncol. 2022. PMID: 36087247 No abstract available.

8

IKZF3 amplification frequently occurs in HER2-positive breast cancer and is a potential therapeutic target.

Lin CY, Yu CJ, Shen CI, Liu CY, Chao TC, Huang CC, Tseng LM, Lai JI. Lin CY, et al. Among authors: lai ji. Med Oncol. 2022 Sep 30;39(12):242. doi: 10.1007/s12032-022-01812-x. Med Oncol. 2022. PMID: 36180600

9

A systemic review of taxanes and their side effects in metastatic breast cancer.

Lai JI, Chao TC, Liu CY, Huang CC, Tseng LM. Lai JI, et al. Front Oncol. 2022 Oct 11;12:940239. doi: 10.3389/fonc.2022.940239. eCollection 2022. Front Oncol. 2022. PMID: 36303832 Free PMC article.

10

The association of trastuzumab with atrial fibrillation and heart failure in breast cancer patients in routine clinical practice: a population-based propensity score matching and competing risk model analysis.

Wu WC, Huang CC, Tsai YF, Lin YS, Feng CJ, Chen YJ, Lai JI, Chao TC, Liu CY, Tseng LM. Wu WC, et al. Among authors: lai ji. Breast Cancer Res Treat. 2023 Feb;198(1):113-122. doi: 10.1007/s10549-022-06753-7. Epub 2022 Dec 31. Breast Cancer Res Treat. 2023. PMID: 36586037 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page